Emerging evidence indicates a link between the increased proportion of regulatory T cells (T regs ) and reduced survival in patients who have been diagnosed with cancer. Cancer stem cells (CSCs) have been indicated to play a vital role in tumour initiation, drug resistance and recurrence. However, the relationship between T regs and CSCs remains largely unknown. Here, we sorted out ovarian cancer stem-like side population (SP) cells and CD133 1 cells to investigate the influence of ovarian CSCs on T regs . Among the various immune-related molecules that we assessed, C-C motif chemokine ligand 5 (CCL5) was the most elevated in ovarian CSCs relative to that in the non-CSCs. The expression of its receptor, C-C motif chemokine receptor 5 (CCR5), was also increased on the surface of T regs in ovarian cancer patients. This receptor-ligand expression profile indicated that ovarian CSCs recruit T regs via CCL5-CCR5 interactions. We further assessed the expression of interleukin (IL)-10 in T regs cultured with different cancer cells. For the first time, to our knowledge, our findings describe the relationship between ovarian CSCs and T regs , and demonstrated that these two cell populations co-operate to promote tumour immune tolerance and enhance tumour progression.
Introduction
Ovarian cancer is the most lethal gynaecological malignancy, accounting for 50% of mortality [1] . Due to the lack of typical clinical symptoms in early stage disease, approximately 75% of patients are diagnosed at an advanced stage [2] . Because of the high recurrence rate, the median overall survival of ovarian cancer patients is still less than 65 months after treatment with surgery and chemotherapy [1] . The concept of cancer stem cells (CSCs) was first proposed due to the similarities between tumour cells and stem cells, with properties such as self-renewal, multi-lineage differentiation potential and capacity to produce organs [3, 4] . CSCs have been defined as a rare subpopulation of cancer cells with the ability to form tumours, selfrenew and undergo differentiation [5] . The existence of CSC was first described in acute myeloid leukaemia [6] , breast cancer [7] and brain tumours [8] . Ovarian CSCs can be separated from tumour cells using surface protein markers, such as c-Kit [9] , CD133 [10] , CD24 [11] , CD44 and CD117 [12] , or via functional assays, such as by taking advantage of their ability to export the DNA-binding dye Hoechst 33342 [13, 14] . CD133, a surface marker of neural stem cells [15] , has been used recently to isolate CSCs from tumours with properties such as self-renewal, tumour initiation and tumour reconstitution [16, 17] . Side population (SP) cells are cells that can export Hoechst 33342. We and others have demonstrated previously that ovarian cancer SP cells exhibit enhanced tumour formation capacity, colony formation ability, chemoresistance and pluripotency [13, 14] . With high levels of expression of stem cell markers, CSCs have been proposed to cause tumour chemoresistance and relapse [18] . Therefore, understanding the role of CSCs in tumour immunity is of great significance for cancer immunotherapy.
Regulatory T cells (T regs ) modulate the immune system negatively under both physiological and pathological conditions [19] . There are four mechanisms by which T regs suppress responder T cells [20] [21] [22] [23] [24] . First, T regs secrete inhibitory cytokines such as interleukin (IL)-35, IL-10 and transforming growth factor (TGF)-b to inhibit T cells directly. Secondly, T regs in the tumour microenvironment produce granzyme B and perforin to suppress responder cells, in the manner of cytotoxic T cells. Thirdly, T regs induce apoptosis in effector cells by metabolic deprivation of the cytokine IL-2, using the specific affinity of IL-2 towards CD25. Lastly, T regs suppress dysfunctional dendritic cells (DCs) and T cells by directly binding with them through surface molecules such as cytotoxic T lymphocyte antigen-4 (CTLA-4) and lymphocyte activation gene-3 (LAG-3).
Tumour-associated antigen (TAA)-specific T cells can infiltrate the tumour microenvironment [25] , and these T cells can also be induced via tumour vaccines [26] . However, the immune system often fails to eliminate cancer cells. It has been demonstrated that tumour cells develop potent, overlapping mechanisms to foster immune privilege by including the infiltration of T regs into the tumour microenvironment [27] [28] [29] [30] . T regs enriched in ovarian carcinoma lead to reduced survival [27] and this has also been observed in many other solid tumours, including melanomas, renal cancer, breast cancer, cervical cancer [31] and colorectal cancer [32] . T regs infiltrate into tumour sites via various mechanisms, such as trafficking, differentiation, expansion and conversion [33] . C-C motif chemokine ligand 22 (CCL22) [27, 34] , CCL5 [30, 35] and CCL28 [28] are responsible for trafficking, while TGF-b and DCs are associated with the activation of T regs induction in the tumour microenvironment [33] .
Currently, many therapeutic strategies targeting T regs , including CD25-specific antibody, CTLA-4-specific antibody and IL-2 immunotoxin, are being developed [33, 36] . However, antibodies targeting T regs fail to induce tumour rejection by the immune system, and thus the mechanisms by which T regs infiltrate into tumour sites need to be elucidated further. CSCs have been reported to inhibit T cell activation and induce T reg recruitment from peripheral blood mononuclear cells (PBMCs) in melanoma and glioma patients [37] . However, only a few researchers have addressed the influence of ovarian CSCs on the recruitment and inhibitory function of T regs . This study aimed to elucidate the effects of ovarian CSCs on T regs in vitro. In this study, we compared the expression of a series of immunosuppression-associated molecules in CSCs and non-CSCs, and found that the expression of indoleamine 2,3-dioxygenase 1 (IDO1), CCL5 and C-X-C motif chemokine ligand 2 (CXCL2) was up-regulated in CSCs, with CCL5 being the most affected. The expression of C-C motif chemokine receptor 5 (CCR5), the receptor of CCL5, was increased in the T regs isolated from ovarian cancer patients, enabling ovarian CSCs to recruit more T regs through the CCL5-CCR5 interactions. We also found that T regs incubated in conditioned medium (CM) from ovarian CSCs expressed higher levels of the inhibitory cytokines IL-10, indicating that T regs in CSC-rich microenvironments display enhanced inhibitory properties. Furthermore, coculture with ovarian cancer cell lines promoted the expression of matrix metalloproteinase-9 (MMP9) in T regs which, in turn, enhanced the invasion of tumour cells. Altogether, for the first time, we demonstrated the effect of ovarian CSCs on the recruitment and inhibitory function of T regs and found that ovarian cancer cells and T regs co-operate to promote tumour progression.
Materials and methods

Ovarian cancer cells culture
The human ovarian cancer cell line highly invasive ovarian cancer cells (HEY) was acquired from the MD Anderson Cancer Center. The cell line HEY A8 was provided by Professor Gong Yang from Fudan University Shang Hai Cancer Center (FUSCC). These two cancer cell lines were cultured in RPMI-1640 with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (GIBCO, Carlsbad, CA, USA). Another ovarian cancer cell line, HO-8910PM, was obtained from Shanghai Institute of Biochemistry and Cell Biology Cell Bank and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. All the cells were incubated at 378C with 5% CO 2 .
Sorting of cancer stem-like cells
Ovarian cancer cell lines HEY and HEY A8 were stained with specific antibodies against human CD133 [phycoerythrin (PE), mouse immunoglobulin (IgG); Miltenyi Biotec, Bergisch Gladbach, Germany] at a density of 1 3 10 7 /10 ml on ice in the dark for 30 min and purified by fluorescenceactivated cell sorting (FACS) (FACSAria III; BD Biosciences, San Jose, CA, USA). The SP cells which pumped out Hoechst 33342 dye were isolated by ultraviolet laser cytometry, as described previously [14] . Briefly, the ovarian cancer cell line HO8910-PM was stained with 5 mg Hoechst 33342 (Sigma, Hiroshima City, Japan) per 1 3 10 6 cells in DMEM with 2% FBS for 90 min at 378C. Verapamil, which 
Real-time polymerase chain reaction (PCR)
Total RNA was isolated using TRIzol reagent, according to the manufacturer's instructions, and then reversetranscribed to cDNA using an RT kit (360A; Takara, Tokyo, Japan). The mRNA expression of interest gene was quantified using the Applied Biosystems real-time PCR system (Life Technologies, Camarillo, CA, USA) with SYBR Green, and the housekeeping gene b-actin served as the control.
The relative expression was analysed using the comparative Ct method (DDCt), and each experiment was repeated at least three times.
Enzyme-linked immunosorbent assay (ELISA)
Isolated CD133 1/-cancer cells or SP/non-SP cells were cultured at 2 3 10 4 /500 ml l for 48 h in 24-well plates, and the conditioned media were collected and stored at 2808C. Freshly isolated T regs were cultured in CD133
1 and CD133
conditioned medium at a concentration of 5 3 10 5 /ml for 24 h, and phorbol myristate acetate (PMA) (PeproTech, Rocky Hill, NJ, USA) with ionomycin (PeproTech) were added to activate T regs for another 12 h. Supernatants collected from the T regs cultured in CD133
1 and CD133 -conditioned media were defined as T 1 reg -and T -reg -conditioned media. CCL5 (DRN00B; R&D Systems, Minneapolis, MN, USA) and CXCL2 (DL-GROb-Hu, DLDEVELOP, CN) levels were measured in the CSC and non-CSC conditioned media; IL-10 (D1000B; R&D Systems) levels were measured in T 1=-reg -conditioned media using the corresponding ELISA kit according to the manufacturers' instructions.
Cell proliferation assay
T regs were precultured in 96-well plates at a density of 2 3 10 4 /well for 24 h. Cell Counting Kit-8 (CCK8; Dojindo, Kumamoto, Japan) solution was added to each well, and the reaction mixture was incubated for 5 h at 378C. The CD133 1 and CD133 -cells were grown in 96-well plates at a concentration of 4 3 10 3 /100 ml for 24 h. Then, 10 ml CCK8 solution was added to each well for 2Á5 h. The proliferation ability of the different cells was measured based on their optical density at 450 nm.
Chemotaxis assay of T regs
Chemotaxis assay was performed in 24-well plates with permeable membranes (5-mm pore, Corning) (Fig. 1a,b) . Mixtures containing recombinant human CCL5 (PeproTech) with 0Á1% bovine serum albumin (BSA) (Sigma) in RPMI-1640, CD133
1 -CM and CD133
--CM or CD133
1 -CM with different concentrations of anti-CCL5 antibodies (PeproTech) were placed into the lower chamber. The chemotaxis assays were performed with this set-up in triplicate and were repeated several times. The chemotaxis assay was performed using two methods. First, purified T regs (100 ml, 1 3 10 5 ) suspended in RPMI containing 0Á1% BSA were added to the upper chambers and incubated for 4 or 6 h at 378C with 5% CO 2 . The T regs that had migrated to the lower chamber were counted with an inverted microscope [38, 39] (Fig. 1a) . For the second method, CD4
1 T cells (100 ml, 5 3 10 5 ) were plated in the top chamber, and the percentage of T regs in the lower chamber among the CD4 1 T cells that had migrated to the lower chamber was analysed with a flow cytometer [28] . The chemotactic index was represented as the ratio of the number of migrated T regs
in the positive group relative to that in the control group [39] (Fig. 1b) .
Invasion assay and co-culture model
For the invasion assay (Fig. 1c) , cells in 24-well culture inserts (8 mm; Corning, New York, NY, USA) coated with diluted Matrigel (1 : 4, in serum-free medium; 40 ml/well) (BD Biosciences) were incubated at 378C for 3h. For the co-culture model, ovarian carcinoma cells were co-cultured with 1 3 10 5 T regs in 12-well plates, which were segregated with a 0Á4-mm polycarbonate membrane to facilitate the exchange of the soluble factors but not cells, and the wells that contained cancer cells or T regs alone were set as the controls. The CM of the co-culture cells (Ca-T reg -CM), the control cancer cells (Ca-CM) or the control T regs (T reg -CM) was collected and diluted 1 : 1 with complete medium and added to the lower chamber of the invasion apparatus [40] , while 3 3 10 4 of HEY A8 or 5 3 10 4 of HO-8910PM cells were placed into the upper chamber. After migration for 24 or 36 h at 378C, the invaded cells were stained with crystal violet and observed under a microscope.
Statistical analysis
The data are presented as the mean 6 standard deviation (s.d.). Real-time PCR and chemotaxis assays were performed in triplicate, and experiments were repeated at least three times. Comparisons were performed using the twotailed Student's t-test or paired t-test. P < 0Á05 was considered significant.
Results
Characterization of immune-associated molecules in CSCs
CSCs have been thought to be responsible for drug resistance and recurrence in cancer. However, the relationship between ovarian CSCs and immune suppression in tumours remains largely unknown. Here, we isolated cancer stem-like SP cells and CD133
1 cells from ovarian carcinoma cell lines HO-8910PM, HEY and HEY A8 by FACS, as described previously [10, 14] (Fig. 2a) . To demonstrate the stemness-associated features of the sorted cells, the expression of pluripotency-related genes, such as Nanog homeobox (Nanog), octamer-binding transcription factor 4 (Oct4) and sex determining region Y box 2 (Sox2), was analysed by real-time PCR. Both CD133 1 cells and SP cells expressed elevated levels of pluripotent genes compared with CD133 -cells and non-SP cells, respectively (Fig. 2b) . Tumour cells can interact with immune cells in the tumour microenvironment through the expression of immune-associated molecules, such as programmed cell death ligand 1 (PD-L1), IDO1, high-mobility group box-1 protein (HMGB1), CCL5 and CXCL2. Among these molecules, PD-L1 and IDO1 can directly suppress T cells [41, 42] , HMGB1 and CCL5 can enhance T reg -mediated immunosuppression [43, 44] and CXCL2 can lead to immune tolerance by attracting myeloid-derived suppressor cells (MDSCs) to the tumour microenvironment [45] .
To explore the role of ovarian CSCs in tumour immune evasion, these immunosuppression-associated molecules were assessed in CSCs and non-CSCs by real-time PCR (Fig. 2c) . There was no difference in the expression of PDL1 between CSCs and non-CSCs. HMGB1 expression was lower in the CD133 1 cancer cells than that in the CD133 -cells, while no difference was found between the SP and non-SP cells. IDO1, CCL5 and CXCL2 were elevated in the CD133
1 cancer cells and SP cells, and CCL5
exhibited the highest increase among these factors. The expression of CCL5 and CXCL2 in the supernatants of CSCs and non-CSCs was analysed further by ELISA. It was found that the CCL5 protein level was higher in the supernatant from CD133 1 cells than that in the supernatant from CD133 -cells. Similar results were obtained for the supernatant from SP cells, indicating that the SP cells secrete a higher level of CCL5 than do the non-SP cells (Fig. 2d) . Using flow cytometry, we found that IDO1 expression was higher in the CD133 1 cells than that in the CD133 -cells (Fig. 2e) . The level of CXCL2 was also higher in the supernatant from CD133
1 cells than that in the supernatant from CD133 -cells (Fig. 2f) .
T regs from ovarian cancer patients expressed higher levels of CCR5 than T regs from healthy controls Cells expressing CCL5 and its receptor CCR5 were attracted via chemokine-receptor interactions [30, 35] . It has been demonstrated that CCR5 is involved in the recruitment of T regs in mice [35] . To determine the expression of CCR5 on T regs , we isolated T regs from ovarian cancer patients. Figure 3a shows the gating strategy and the identification of T regs . First, the CD4 1 T cells were gated from the PBMCs. Subsequently, the CD25 1 CD127 -/low T regs , representing a distinct fraction, were gated within the CD4 1 T cells. Then, a four-colour staining strategy was used to measure the intracellular FoxP3 expression in the CD4 1 CD25 1 CD 127-/low T regs , and we found that the majority of these T regs expressed FoxP3. We then analysed CCR5 expression on T regs from the PBMCs isolated from healthy volunteers (n 5 10) and ovarian cancer patients (n 5 10) with a flow cytometer (Fig. 3b,c) . The level of CCR5 was increased in the T regs from the ovarian cancer patients (P-T regs ) relative to that in the T regs from healthy controls (H-T regs ). However, the conventional T cells (T conv ) from the healthy volunteers (H-T conv ) and ovarian cancer patients (P-T conv ) displayed a lower degree of CCR5 expression compared with the H-T regs and P-Tregs, respectively. Thus, these results suggested that T regs of ovarian cancer patients displayed increased CCR5 expression, which might enable the ovarian CSCs to recruit T regs preferentially to the tumour microenvironment through ligand-receptor interaction. Next, the effect of CCL5 on the recruitment of T regs was examined by two chemotaxis assays using culture plates with 5 mm pore-containing permeable membranes. For the first method, the CD4 1 CD25 1 CD127 -/low T regs sorted freshly from PBMCs were added to the upper chamber of the chemotaxis assay set-up to test their migration towards recombinant human CCL5, and the migrated T regs in the lower chamber were counted with an inverted microscope. The chemotactic index of T regs in the group with CCL5 was approximately two-fold higher than that in the group with blank control. Additionally, this migration of the T regs towards CCL5 could be blocked by anti-CCL5 antibodies (Fig. 3d) . For the second method, we added CD4 1 T cells sorted from PBMCs to the upper chamber to migrate towards CCL5 in the lower chamber, and the percentage of T regs in the lower chamber was measured by flow cytometry. The percentage of T regs in the lower chamber was higher in the CCL5 group than that in the control group, indicating that T regs were the predominant population among the CD4 1 T cells that interact with CCL5 in vitro (Fig. 3e) .
Ovarian CSCs recruited T regs through chemokine CCL5
To determine the relationship between ovarian CSCs and T reg recruitment via the CCL5-CCR5 axis, we performed a chemotaxis assay using two methods with CMs collected from different types of cancer cell populations. First, isolated T regs were added to the upper chamber of the chemotactic apparatus, and the chemotactic index of T regs in the CD133 1 -CM group was found to be (1Á7 6 0Á033)-and (1Á3 6 0Á077)-fold higher than the chemotactic indices of T regs in the CD133 --CM groups using CM from HEY and HEY A8 cell lines, respectively, indicating that ovarian CSCs exert a greater chemotactic effect on T regs than do non-CSCs (Fig. 4a) . Secondly, to confirm the preferential recruitment of T regs by CD133
1 -CM, we added CD4 1 T cells into the upper compartments of the chemotaxis apparatus and assessed their migration towards CD133 1   -CM  and CD133 --CM in the lower chamber. After 6 h, the CD4 1 CD25 1 CD127 -/low T regs in the lower and upper chambers were analysed via flow cytometry. The results showed that the CD133 1 -CM recruited more T regs to the lower chamber than did CD133 --CM, while the percentage of T regs in the upper chamber of the CD133 1 group was lower than that of the CD133 -group (Fig. 4b,c) . The percentage of T regs in the lower chamber was higher than that in the upper chamber for both the CD133 --CM and CD133
1 -CM groups, indicating that the T regs were attracted preferentially to the CM of CD133 1 and CD133 -cells than the other CD4 1 T cells.
To identify whether CCL5 plays a role in the CSCdependent preferential recruitment of T regs , different concentrations of human CCL5-neutralizing antibodies were added to the CD133 1 -CM to block the CCL5-related chemotaxis. The results showed that the recruitment of T regs by CD133
1 -CM could be abrogated completely when the concentration of anti-CCL5 antibody was higher than 15 ng/ml, and the blocking effect was dose-dependent below 15 ng/ml (Fig. 4d) , suggesting that the recruitment of T regs by CD133
1 cells was dependent upon CCL5. Taken 1 -CM was abrogated by different concentrations of anti-CCL5 antibody. The group with 500 ng/ml anti-CCL5 antibody was used to define the reference chemotactic index in this panel. *P < 0Á05 and **P < 0Á01.
Ovarian cancer stem cells and immunology together, a direct link between ovarian CSCs and T reg recruitment through CCL5 was established in this study.
Ovarian CSCs promoted the inhibitory function and proliferation of T regs
As T regs can exert their function on effector T cells through inhibitory cytokines, such as IL-10 and TGF-b [24] , the effect of CSCs on the function of T regs was assessed by measuring IL-10 and TGF-b levels using flow cytometry and ELISA in T regs that were incubated in CD133 --CM and CD133
1 -CM. (Fig. 5a) . Additionally, the level of IL-10 was higher in T T regs have been proposed to be enriched in the tumour microenvironment via four mechanisms, including trafficking, differentiation, expansion and conversion [33] . To investigate whether CSCs can stimulate the expansion of T regs , we pre-incubated the sorted T regs in CD133
--CM or CD133 1 -CM in 96-well plates for 24 h, and the T regs incubated in the RPMI (with 10% FBS) were used as controls. Then, CCK8 reagent was added to the cells, and the cells were incubated for another 5 h. Compared with the control medium, CD133
--CM and CD133 1 -CM both promoted proliferation in T regs (Fig. 5c ).
T regs enhanced cancer cell invasion by increasing MMP9 expression
In our present study, T regs have been demonstrated to be recruited to the tumour microenvironment partly by ovarian CSCs. To determine whether these T regs affected tumour progression, we used co-culture experiments in which isolated T regs were placed into the upper chamber, while ovarian cancer cells were in the lower chamber, segregated by a 0Á4 mm polycarbonate membrane to facilitate the exchange of soluble factors but not of cells. We first focused on the expression of MMPs, and found no obvious change in the MMP9 expression in HEY cells in the presence of T regs ; 1 -CM. *P < 0Á05 and **P < 0Á01.
however, MMP9 expression was elevated in the T regs after co-culturing (Fig. 6a) . Similar results were found when other cell lines, including HEY A8(A8) and HO-8910PM (PM), T reg -A, T reg -H and T reg -P represented T regs that interacted with the cancer cell lines HEY A8, HEY and HO-8910-PM, respectively. To identify further the changes in MMP9 expression in T regs after culturing them with cancer cells, indirect fluorescence immunoassay-based flow cytometry was used to evaluate MMP9 expression at the protein level, and the relative expression of MMP9 in the co-cultured T regs was 1Á74 (6 0Á1)-fold higher than that of mono-cultured T regs (Fig. 6b,d) .
To investigate whether the increased MMP9 levels in the co-cultured T regs could affect the invasion of cancer cells, we collected the conditioned medium from co-cultured cancer cells and T regs (Ca-T reg -CM) and conditioned medium from mono-cultured cancer cells (Ca-CM) to add to the lower chamber of the invasion apparatus, which was equipped with a 8-mm pore polycarbonate membrane and coated with Matrigel, and cancer cells were added to the upper chamber to migrate towards the CMs to test the influence of T regs on the invasion of cancer cells. The data showed that compared with Ca-CM, Ca-T reg -CM promoted the invasion of the cancer cell lines HEY A8 and HO-8910PM (Fig. 6c,d ). To identify whether T regs themselves induced the invasion of ovarian tumour cells, we collected medium from mono-cultured T regs (T reg -CM) to add to the lower chamber of the invasion apparatus and tested the invasion of cancer cells. The results showed that T regs -CM enhanced the invasion of cancer cells to a much greater extent than did Ca-CM. Taken together, cancer cells upregulated MMP9 expression in T regs which, in turn, promoted the invasion of tumour cells via MMP9.
Discussion
Being at the top of the differentiation hierarchy, CSCs, which play an important role in tumorigenesis, may evade immune rejection preferentially, but the role of CSCs in tumour immune tolerance remains largely unclear. In the present study, we showed that both the CD133 1 cancer stem-like cells and the SP cells isolated from ovarian cancer cell lines displayed elevated expression of immunosuppressionassociated molecules such as CCL5, CXCL2 and IDO1, which enabled the CSCs to evade immune response. Interestingly, some recent studies also indicated that the expression of tumour-associated antigens (TAA) is decreased in CSCs, and major histocompatibility complex (MHC) molecules and natural killer group 2, member D (NKG2D) ligand molecules are also reduced or absent in CSCs [37, 46, 47] . Other than the aberrant expression of immune-associated molecules, CSCs can also dampen the proliferation of T cells and induce the infiltration of T regs in melanoma [37] . All these studies revealed the role of CSCs in promoting immune tolerance. CD4 1 CD25 1 CD127 -/low T regs , a subpopulation of CD4 1 T cells, help to maintain immune homeostasis by inhibiting immune responses under physiological conditions [19] . Recently, emerging evidence indicated that the proportion of T regs is increased in various types of solid tumour, which is associated with poor prognosis [31] . However, the effect of CSCs on the recruitment of T regs remains unknown. We found that the CD133 1 cancer cells expressed high levels of CCL5, a molecule that has been reported previously to be expressed highly in ovarian CSCs to promote cancer invasion and migration by the up-regulation of MMP9 and induction of epithelial-mesenchymal transition (EMT) [10, 48] . However, the relationship between CCL5 and T regs recruitment has not been explored. The chemokines CCL5 and CCL22 have been reported to be responsible for T reg recruitment [27, 30, 35, 44] . In this study, we showed that CCL5 could attract T regs , and CD133 1 -CM recruited more T regs than did CD133 --CM, which could be blocked by antibodies against human CCL5, suggesting that the recruitment of T regs by CSCs rely upon CCL5. Our results, combined with those from former reports, indicate that CCL5 expression in ovarian carcinoma CSCs has a profound effect on both T regs recruitment and tumour metastasis, and anti-CCL5 antibodies might thus provide a novel strategy for immunotherapy in ovarian cancer patients. T regs have been reported to display higher levels of CCR5, a receptor of CCL5, than effector T cells. CCR5 is responsible for the migration of T regs in murine pancreatic cancer and in fungal infections [35, 49] . However, the expression of CCR5 on T regs isolated from ovarian cancer patients was not understood clearly. Here, we found that T regs expressed more CCR5 than did the effector T cells, which was consistent with previous reports. CCR5 expression on T regs isolated from ovarian cancer patients was significantly higher than that of T regs isolated from healthy volunteers. Furthermore, CCL5 has been reported to be elevated in ovarian cancer patients [50] , which might account for the accumulation of T regs in the tumour microenvironment of ovarian cancer patients.
Inhibitory cytokines, such as IL-10 and TGF-b, are attributable for the inhibitory function of T regs , but it is unclear whether ovarian CSCs are involved in affecting the secretion of these inhibitory cytokines by T regs . CSCs in melanoma have been demonstrated to promote PBMCs to secrete IL-10 in a B7.2-dependent manner [37] . In this study, we showed that CD133 1 -CM increased IL-10 expression significantly by T regs in vitro, but had no effect on TGF-b secretion, suggesting that cancer stem cells probably promoted immune privilege partly by the induction of IL-10 secretion in T regs .
T regs inhibit immune response by inducing apoptosis in T cells and deregulating antigen-presenting cell dysfunction in the tumour microenvironment [33] . However, whether T regs recruited by CSCs can affect tumour cells directly is still unclear. Previous studies have suggested that tumourinfiltrating immune cells, such as myeloid immune suppressor cells, neutrophils, mast cells and macrophages, secrete MMP9 to promote tumour survival, metastasis, angiogenesis and intravasation [51] [52] [53] [54] [55] . Tumour-specific T cells were reported to promote tumour cells to express MMP9 [40] , and MMP9 was correlated with the proportion of T regs in laryngeal cancer [56] . Here, we provided evidence that co-culture with tumour cells induced MMP9 expression in T regs . Our results also showed that Ca-T reg -CM promoted a higher degree of invasion in tumour cells compared with Ca-CM and T reg -CM, which might be attributed to the increased MMP9 expression in T regs . However, the effect of tumour cells on MMP9 expression in T regs should be elucidated further with clinical cancer tissues to investigate whether the same phenomemon is involved in the tumour microenvironment in vivo.
In summary (Fig. 7) , our data provide evidence for the first time that ovarian cancer stem-like cells express higher levels of immunosuppression-associated molecules, such as CCL5, CXCL2 and IDO1, and recruit T regs through CCL5. We also show that T regs from ovarian cancer patients express high levels of CCR5, the receptor for CCL5, which facilitates the recruitment of T regs by ovarian cancer stemlike cells. Cancer stem-like cells can also increase IL-10 expression in T regs . In exchange, T regs promote the invasion of ovarian cancer cells through MMP9, the expression of which can be enhanced by co-culture of T regs with cancer cells.
